Cardiogen
Cardiogen (Ala-Glu-Asp-Arg) is a potent Khavinson tetrapeptide bioregulator developed for absolute cardioprotection and high-stakes myocardial recovery. Frequently utilized in cardiac rehabilitation, it serves as the foundation for reversing age-related heart failure, rapidly accelerating recovery following a catastrophic myocardial infarction, and shielding elite athletes from the extreme cardiac stress induced by intensive hypertrophy protocols.
Quick Stats
Scientific Data
Mechanism of Action
Cardiogen (Ala-Glu-Asp-Arg) is a tetrapeptide bioregulator targeting myocardium (heart muscle). It stimulates the proliferation and differentiation of myocardial cells and restores expression of cardiac-specific proteins. Khavinson research demonstrates improvements in cellular metabolism of cardiomyocytes, reduced hypertrophy, and enhanced recovery following ischemia or myocardial infarction.
Source: PMID: 15677927
Background & History
Cardiogen (AEDR) targets cardiomyocytes for cardiac tissue resilience.
Research Use Cases
- ✓Cardiac tissue support in aging
- ✓Post-infarction recovery protocols
- ✓Cardiovascular health maintenance
Dosing Protocol
| Typical Dose | 10-20 mg/day (oral) or 1-2 mg SC |
| Frequency | 1× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
| Common Vial Sizes | 5 mg, 10 mg |
Dosing Protocols
Khavinson Protocol
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 1000–20000 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 771 mcg | 8100 mcg | 15429 mcg |
| 140 lb(63 kg) | 900 mcg | 9450 mcg | 18000 mcg |
| 160 lb(73 kg) | 1043 mcg | 10950 mcg | 20857 mcg |
| 180 lb(82 kg) | 1171 mcg | 12300 mcg | 23429 mcg |
| 200 lb(91 kg) | 1300 mcg | 13650 mcg | 26000 mcg |
| 220 lb(100 kg) | 1429 mcg | 15000 mcg | 28571 mcg |
| 250 lb(113 kg) | 1614 mcg | 16950 mcg | 32286 mcg |
💉 For exact syringe units based on your vial concentration, use the Cardiogen Reconstitution Calculator →
Administration
Expected Timeline
Who Is It For?
Cardiac / Heart Aging
LowMyocardial bioregulator. Targets age-suppressed cardiac gene expression.
Reconstitution Example
Safety & Considerations
Research peptide. Extensively used in Russian clinical protocols. Excellent safety profile in elderly populations.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Standard Khavinson protocol.
Synergies & Common Stacks
Cardiogen (synthetic) + Chelohart (cardiac Cytomax) = layered cardiac bioregulator support.
Cardiogen (heart muscle) + Vesugen (vascular endothelium) = comprehensive cardiovascular protocol.
Dosing Quick Reference
Frequently Asked Questions
How does Cardiogen differ from Chelohart?▼
References
- Khavinson VKh et al. “"Cardiogen stimulates proliferation of myocardial cells".” Bulletin of Experimental Biology and Medicine (2009). PMID: 19702220
📚 Related Articles
Get Cardiogen from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.
Affiliate link · Full review